GOTA: NOVAS PERSPECTIVAS NO TRATAMENTO DA HIPERURICEMIA E NO CONTROLE DAS CRISES
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Gout is a chronic inflammatory disease associated with persistent hyperuricemia and the deposition of monosodium urate crystals, with high prevalence and a significant impact on quality of life. Traditionally characterized by acute episodes of arthritis, gout is now recognized as a systemic condition, frequently associated with metabolic comorbidities. This chapter aimed to analyze, through a narrative literature review, new perspectives in the treatment of hyperuricemia and the control of gout flares. The search was conducted in the PubMed, SciELO, ScienceDirect, and LILACS databases, including studies published between 2015 and 2025. The results indicate that treat-to-target therapeutic strategies, combined with the use of urate-lowering therapies and appropriate management of inflammatory flares, promote better disease control and reduce the recurrence of acute episodes. New pharmacological options have expanded treatment possibilities, especially for patients who are refractory to or have contraindications to conventional therapies. It is concluded that effective gout management requires an integrated, continuous, and patient-centered approach, combining pharmacological treatment, lifestyle interventions, and longitudinal follow-up to optimize clinical outcomes.
Fields of Study & Subjects
Gout
Hyperuricemia
Uric Acid
Drug-Induced Adverse Reactions
Biochemical and Molecular Research
Publication details
- Pages
- 60–68
- Publication date
- 24 March 2026
- Language
- EN
- Document type
- Book chapter